Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2025-12-24 @ 4:43 PM
NCT ID:
NCT00582166
Eligibility Criteria:
Inclusion Criteria:
* Patients with biopsy-proven non-hodgkins lymphoma of follicular grade 1, 2, or 3
* Meeting FLIPI criteria for intermediate or high risk.
* No prior chemotherapy, radiotherapy or immunotherapy for lymphoma;
* Patients may not have known HIV infection, and must not be Hepatitis B Surface Antigen positive.
Exclusion Criteria:
* May not be pregnant or breastfeeding, have documented CNS (Central Nervous System) disease, G-CSF (Granulocyte Colony Stimulating Facto) or GM-CSF (Granulocyte/Macrophage Colony Stimulating Factor) within 2 weeks prior
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00582166
Study Brief:
Protocol Section:
NCT00582166